
Life Sciences
Business challenges posed by tech, biotech and life sciences companies are complex and require specialised knowledge to resolve. FD’s extensive experience supporting these industries while they innovate and bring products and services to market makes us a trusted resource as companies transform and grow.
Featured Insight
-
How to Account for Series Funding Rounds Under UK GAAP
Read more: How to Account for Series Funding Rounds Under UK GAAPA practical guide to accounting for Series funding rounds under UK GAAP (FRS 102), covering equity, convertibles, SAFEs and share based payments.

Recent Insights & Resources
More on Healthcare & Life Sciences
-
How to Account for Series Funding Rounds Under UK GAAP
Read more: How to Account for Series Funding Rounds Under UK GAAP
-
Balancing Cost, Innovation and Incentives: The R&D Subcontracting Challenge for UK Businesses
Read more: Balancing Cost, Innovation and Incentives: The R&D Subcontracting Challenge for UK Businesses













